At the 2017 European Association of Osseointegration (EAO) Congress in Madrid, Spain, Nobel Biocare announced it has entered into a partnership agreement with Dentalpoint AG, a leader in ceramic dental implants, to add a zirconia implant solution to its portfolio.
The partnership with Dentalpoint AG will add a new implant option to Nobel Biocare’s leading range of titanium dental implants with the clinically proven TiUnite surface. The innovations from Dentalpoint AG, known for its ZERAMEX® implant brand, are intended to help clinicians meet patient demand for metal-free solutions and high-end esthetics.
Utilizing breakthrough manufacturing technology, Dentalpoint AG is the developer of the first completely metal-free two-piece bone level implant system with internal connection that is not dependent on cement. Screw-retained with an innovative metal-free screw, the two-piece nature of the system means that clinicians can treat patients with a zirconia implant using protocols similar to those they are familiar with for traditional implants. It also offers greater restorative flexibility compared with existing one-piece or cement-retained ceramic implant options.
A solution featuring this first-of-a-kind technology will be available from Nobel Biocare in early 2018. The introduction of a ceramic implant further extends Nobel Biocare’s comprehensive range of innovative solutions for Immediate Function and excellent esthetics.
Hans Geiselhöringer, President, Nobel Biocare said:
“Nobel Biocare has been actively researching ceramic dental implant technology for many years. In Dentalpoint AG we have now found a partner and solution that meet the high standards we and our customers demand. As a result of this partnership, Nobel Biocare customers will very soon be able to offer their patients the very first completely metal-free screw-retained two-piece implant solution with an internal connection. It is the ideal addition to our already extensive range of solutions that maintain tissue-health and deliver long-lasting esthetics.”
Jürg Bolleter, President, Dentalpoint AG said:
“As interest in ceramic implants among patients grows, so too does demand around the world. We are excited by the potential of this partnership with a company of the reputation and heritage of Nobel Biocare and, most importantly, the role it will play in helping more clinicians and patients across the globe to benefit from our standard-setting ceramic implant innovations.”
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive®, NobelParallel®, Brånemark System® and NobelReplace®), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), treatment planning and guided surgery solutions (NobelClinician® and NobelGuide®) and biomaterials (creos™). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at five sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.
Founded in 2005 by Swiss entrepreneur and current president Jürg Bolleter, Dentalpoint AG set pioneering standards in the segment of dental medical implants. The registered trademark ZERAMEX® represents an aesthetic and metal-free all-ceramic implant system that addresses a growing patient need.
